Use of spirostenols to treat mitochondrial disorders

Details for Australian Patent Application No. 2006231451 (hide)

Owner Georgetown University Samaritan Pharmaceuticals, Inc.

Inventors Papadopoulos, Vassilios; Yao, Wenguo; Lecanu, Laurent; Tillement, Laurent; Greeson, Janet

Agent Griffith Hack

Pub. Number AU-A-2006231451

PCT Pub. Number WO2006/107902

Priority 60/667,229 01.04.05 US; 60/697,518 08.07.05 US

Filing date 31 March 2006

Wipo publication date 12 October 2006

International Classifications

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 27/00 (2006.01) Drugs for disorders of the senses

Event Publications

25 October 2007 PCT application entered the National Phase

  PCT publication WO2006/107902 Priority application(s): WO2006/107902

27 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006231452-Polymeric micelles for drug delivery

2006231420-Pressure generation device